Novagali Pharma Overview

  • Founded
  • 2000
  • Status
  • Acquired/​Merged
  • Employees
  • 44
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $139M
Latest Deal Amount

Novagali Pharma General Information


Developer of drug delivery technologies for ophthalmologists. The company enables the development of improved versions of validated drugs targeting dry eye, allergy, glaucoma and retinopathies.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 1 rue Pierre Fontaine
  • Genavenir IV
  • 91058 Evry cedex
  • France
+33 01 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Novagali Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 21-Dec-2011 $139M 000.00 00000 Completed Generating Revenue
6. IPO 21-Jul-2010 000.00 000.00 000.00 Completed Generating Revenue
5. Grant 01-Apr-2010 000.00 000.00 Completed
4. Later Stage VC (Series D) 26-Sep-2009 000.00 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 01-Apr-2006 000.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series B) 20-Sep-2004 $17.3M $21.1M Completed Product Development
1. Early Stage VC (Series A) 01-Jan-2000 $3.84M $3.84M Completed Product Development
To view Novagali Pharma’s complete valuation and funding history, request access »

Novagali Pharma Executive Team (4)

Name Title Board Seat Contact Info
Raphael Wisniewski Advisor
You’re viewing 1 of 4 executive team members. Get the full list »

Novagali Pharma Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Novagali Pharma Former Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
123 Investment Managers Asset Manager Minority 000 0000 000000 0
Andera Partners PE/Buyout Minority 000 0000 000000 0
Auriga Partners (Paris) Venture Capital Minority 000 0000 000000 0
Bpifrance Sovereign Wealth Fund Minority 000 0000 000000 0
CDC Enterprises PE/Buyout Majority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »